In-silico studies of glutathione peroxidase4 activators as candidate for multiple sclerosis management
Multiple sclerosis (MS) is an autoimmune and inflammatory demyelinating disease of the central nervous system (CNS) that affects approximately 2.8 million people worldwide. Although numerous studies have been conducted to investigate novel therapeutic targets and lead compounds, few drug choices are...
Saved in:
| Main Authors: | Alaa Alnoor Alameen, Mohnad Abdalla, Hanan M. Alshibl, Monerah R. AlOthman, Manal M. Alkhulaifi, Tabyan O. Mirgany, Rasha Elsayim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2022-11-01
|
| Series: | Journal of Saudi Chemical Society |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1319610322001363 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Determination of glutathione peroxidase (GSH-Pex) activity in sera & RBCs of Iraqi Women With Breast Tumors
by: Peri H. Saifullah, et al.
Published: (2009-12-01) -
Glutathione Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Cancer Treatment
by: Paula Iglesias-Matesanz, et al.
Published: (2024-11-01) -
Correlation of ferritin and glutathione peroxidase 4 (GPX4) level as a marker of ferroptosis process in endometrioma
by: Rina Nulianti, et al.
Published: (2025-02-01) -
Glutathione peroxidase 4 as a potential biomarker for atrial fibrosis and recurrence of atrial fibrillation
by: Tong Liu, MD, et al.
Published: (2025-05-01) -
Superoxide dismutase and glutathione peroxidase content in children with type 1 diabetes mellitus
by: Yu. V. Bykov, et al.
Published: (2023-08-01)